Your email has been successfully added to our mailing list.

×
-0.0112359550561796 -0.00374531835205985 -0.00624219725343319 0.00499375780274668 -0.0174781523096129 -0.0349563046192259 -0.048689138576779 -0.0386766541822721
Stock impact report

Intensity Therapeutics regains compliance with Nasdaq's minimum bid price requirement [Seeking Alpha]

Intensity Therapeutics, Inc. (INTS) 
Company Research Source: Seeking Alpha
Nasdaq confirmed that for the last 10 consecutive business days, from February 19, 2026, through March 4, 2026, the closing bid price of the company's common stock was at or above $1.00, and as a result, the matter is now closed. INTS premarket to $7.79. Source: Press Release More on Intensity Therapeutics Seeking Alpha's Quant Rating on Intensity Therapeutics Historical earnings data for Intensity Therapeutics Financial information for Intensity Therapeutics Show less Read more
Impact Snapshot
Event Time:
INTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for INTS alerts
Opt-in for
INTS alerts

from News Quantified
Opt-in for
INTS alerts

from News Quantified